03624nam 22004815 450 991073146880332120230610113711.03-031-28536-010.1007/978-3-031-28536-3(MiAaPQ)EBC30591726(Au-PeEL)EBL30591726(DE-He213)978-3-031-28536-3(PPN)272261653(CKB)26895857000041(EXLCZ)992689585700004120230610d2023 u| 0engurcnu||||||||txtrdacontentcrdamediacrrdacarrierDiabetes and COVID-19 Considerations and Clinical Management /edited by Alyson K. Myers1st ed. 2023.Cham :Springer International Publishing :Imprint: Springer,2023.1 online resource (225 pages)Contemporary Endocrinology,2523-3793Print version: Myers, Alyson K. Diabetes and COVID-19 Cham : Springer International Publishing AG,c2023 9783031285356 COVID-19: epidemiology, etiology, clinical manifestations, diagnosis, therapeutic options, and prevention -- Pathophysiology: How COVID-19 Impacts the Pancreas and Peripheral Insulin Resistance -- Risk of COVID-19 in Persons with Diabetes -- Pathophysiology of Lung Dysfunction in Diabetes -- Diabetic kidney disease and COVID-19 -- The Impact of COVID-19 on Diabetic Foot Ulcers -- Co-morbid obesity and its impact on diabetes and COVID-19 -- Overview of Inpatient Mgt of Diabetes and COVID 19 -- Management of critically ill persons with COVID-19 and diabetes -- Managing Outpatient Diabetes in Persons with COVID-19 and Diabetes -- The Use of Diabetes Technology In Persons With Diabetes and Coronavirus 2019 (COVID-19) -- COVID-19 Vaccination in Persons with Diabetes -- COVID-19 Vaccination in Persons with Diabetes -- Long-haul COVID Symptoms in Person with Diabetes.Managing COVID-19 alone can be a difficult in many cases, but for persons with pre-existing conditions such as diabetes the challenge can be all the greater, and specific considerations need to be taken when prescribing treatment to manage them. This book is a culmination of scientific work driven by personal conviction to enhance the care provided to the vulnerable populations COVID-19 patients with diabetes. It spans topics from the epidemiology and predictors of complications and increased mortality in COVID-19, to in-depth discussion of the pathophysiology of the disease. Pathophysiology of COVID-19 is addressed comprehensively as common soil pathogenetic pathways, and by organ system such as the lung, the kidney and most pertinently for diabetes, the diabetic foot ulcers and diabetes co-morbidities. A multi-disciplinary approach was needed to manage these complex patients; thus, the authors represent a variety of disciplines including pharmacology, endocrinology, nephrology, infectious diseases, podiatry, vascular surgery, pulmonary/critical care, and general medicine. Written by experts in the field, Diabetes and COVID-19: Considerations and Clinical Management is a blueprint for treatment of patients with both conditions. .Contemporary Endocrinology,2523-3793EndocrinologyEndocrinologyEndocrinology.Endocrinology.616.24144Myers Alyson K1369169MiAaPQMiAaPQMiAaPQBOOK9910731468803321Diabetes and COVID-193395247UNINA